Biography
Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is a Professor Utah Tech University and directs the Center for Precision Medicine. Latterly he was Executive Clinical Director for Precision Health across the 33 hospital, ~400 clinic Intermountain Health system. He has implemented or advised implementation of precision medicine at integrated health systems, academic medical centers, and community practices in the USA and Internationally. Dr McLeod was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council and an NIH/NCI intramural reviewer for over a decade. Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies. Howard has published over 600 peer reviewed papers on precision medicine, pharmacogenomics, or clinical pharmacology with collaborators from over 40 countries. He continues to work to advance cutting-edge healthcare and early adoption of high impact innovation.
Financial Disclosure
Cofactor Genomics
Advisor
MyCareGorithm
Advisor
EviCORE
Advisor
Foremaster Health
Ownership Interest
Clarified Precision Medicine
Ownership Interest
Genovation Health
Ownership Interest